In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
OPERATING CASH FLOW | | | | | | | | |
Net earnings (loss) | | -130.0 | 72.0 | 56.0 | -263.3 | 37.4 | -122.0 | -54.0 |
|
Adjustments to reconcile net earnings to operating cash flow: | | | | | | | | |
Impairment | | | | -63.0 | 137.4 | | 101.0 | 47.0 |
(Earnings) loss from equity method investments, net of distributions | | | -7.0 | -3.0 | -0.1 | | -3.0 | 1.0 |
Loss (gain) on sales of assets (including AMECO-South America in 2023) | | 58.0 | | | -2.2 | | -2.0 | 2.0 |
Stock-based compensation | | 16.0 | 7.0 | 13.0 | 7.0 | | 11.0 | 10.0 |
Deferred taxes | | 12.0 | -15.0 | 1.0 | 1.7 | | 5.0 | -5.0 |
Changes in assets and liabilities | | -133.0 | -12.0 | -203.0 | 155.9 | | 47.0 | -230.0 |
Other | | -2.0 | | -4.0 | | | | |
Operating cash flow | | -161.0 | 55.0 | -188.0 | 244.9 | 37.4 | 76.0 | -230.0 |
|
INVESTING CASH FLOW | | | | | | | | |
Purchases of marketable securities | | -71.0 | -78.0 | -158.0 | -75.0 | | -25.0 | -6.0 |
Proceeds from the sales and maturities of marketable securities | | 82.0 | 161.0 | 82.0 | 15.0 | | 12.0 | 11.0 |
Capital expenditures | | -20.0 | -13.0 | -10.0 | -20.5 | | -16.0 | -30.0 |
Proceeds from sales of assets (including AMECO-South America in 2023) | | 22.0 | 128.0 | 3.0 | 20.3 | | 35.0 | 8.0 |
Investments in partnerships and joint ventures | | -2.0 | -22.0 | -24.0 | 0.4 | | -12.0 | -48.0 |
Other | | 2.0 | 6.0 | 2.0 | 3.0 | | | |
Investing cash flow | | 13.0 | 182.0 | -105.0 | -56.9 | | 65.0 | -65.0 |
|
FINANCING CASH FLOW | | | | | | | | |
Purchases and retirement of debt | | -137.0 | | | | | | |
Dividends paid on CPS | | -10.0 | 10.0 | -10.0 | 9.4 | | | |
Distributions paid to NCI | | | -5.0 | -7.0 | -88.6 | | -10.0 | -8.0 |
Capital contributions by NCI | | 1.0 | | | 0.3 | | 64.0 | 42.0 |
Taxes paid on vested restricted stock | | -10.0 | | -5.0 | 4.4 | | | -4.0 |
Other | | -7.0 | -1.0 | -1.0 | -3.4 | | 5.0 | -5.0 |
Financing cash flow | | -161.0 | -38.0 | -16.0 | -95.8 | | 627.0 | 28.0 |
Effect of exchange rate changes on cash | | 7.0 | -38.0 | 13.0 | -8.2 | | 5.0 | 6.0 |
Increase (decrease) in cash and cash equivalents | | -302.0 | 161.0 | -296.0 | 83.9 | | 773.0 | -261.0 |